Stock listing

NASDAQ:APTX Aptinyx Inc Stock

Follow Aptinyx Inc into a list and get an email when it puts out news.

Delisted NASDAQ:APTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:APTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Aptinyx Inc on 6ix

Calls
8 calls with a replay · 8 with a transcript · latest Nov 8, 2022
Decks
6 decks · latest Feb 9, 2022

Events

CallWhenStatus
Aptinyx (APTX) Q3 2022 Earnings CallTue, Nov 08, 2022 · 5:00 PM ETReplay
Aptinyx (APTX) Q2 2022 Earnings CallThu, Aug 04, 2022 · 5:00 PM ETReplay
Aptinyx (APTX) Q1 2022 Earnings CallThu, May 12, 2022 · 5:00 PM ETReplay
Aptinyx (APTX) Q4 2021 Earnings CallWed, Mar 23, 2022 · 5:00 PM ETReplay
Aptinyx (APTX) Q3 2021 Earnings CallTue, Nov 09, 2021 · 5:00 PM ETReplay
Aptinyx (APTX) Q2 2021 Earnings CallTue, Aug 10, 2021 · 5:00 PM ETReplay
Aptinyx (APTX) Q1 2021 Earnings CallThu, May 13, 2021 · 5:00 PM ETReplay
Aptinyx (APTX) Q4 2020 Earnings CallWed, Mar 24, 2021 · 5:00 PM ETReplay

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (February 2022)Technical63 slidesFeb 9, 2022
Investor Presentation (June 2021)Investor deck57 slidesJun 15, 2021
Investor Presentation (June 2021)Investor deck34 slidesJun 15, 2021
Technical Presentation (October 2020)Technical24 slidesOct 20, 2020
Investor Presentation (August 2020)Investor deck43 slidesAug 5, 2020
Investor Presentation (March 2019)Investor deck16 slidesMar 13, 2019

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James N Topper
Other companies: Attovia Therapeutics, Inc. (Director · Since at least Aug 4, 2026); NewAmsterdam Pharma Company N.V. (Director · Since at least Dec 29, 2023); Phathom Pharmaceuticals, Inc. (Director · Since at least Oct 24, 2019); Frazier Lifesciences Acquisition Corp (Chief Executive Officer, Director · Dec 8, 2020 – Dec 11, 2020 · Past); Entasis Therapeutics Holdings Inc (Director · Sep 25, 2018 – Jan 18, 2019 · Past); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Nov 17, 2020 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); AnaptysBio, Inc. (Director · Jan 25, 2017 – Jan 6, 2023 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Feb 14, 2017 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – Jun 5, 2013 · Past); Amicus Therapeutics Inc (Director · Jun 15, 2010 – Jun 12, 2014 · Past)
Director · Jun 20, 2018 – Mar 31, 2020 · Past
Robert J. Hombach
Other companies: Seaport Therapeutics, Inc. (Director · Since at least Apr 30, 2026); Henry Schein, Inc. (Director · Since at least Jan 29, 2025); Embecta Corp. (Director · Since at least Mar 20, 2022); BioMarin Pharmaceutical Inc. (Director · Since at least Sep 29, 2017); CarMax Inc (Director · Apr 1, 2018 – Jul 2, 2021 · Past); Baxalta Inc (EVP. CFO and COO · Jul 1, 2015 – Jun 3, 2016 · Past)
Director · Jun 20, 2018 – May 26, 2022 · Past
Henry Gosebruch
Other companies: ANI Pharmaceuticals, Inc. (Director · Since at least Aug 19, 2026); Neumora Therapeutics, Inc. (President & CEO, Director · Sep 14, 2023 – Feb 14, 2024 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); AbbVie Inc. (EVP, Chief Strategy Officer · Oct 30, 2017 – May 16, 2022 · Past)
Director · May 6, 2019 – May 26, 2022 · Past
Gilmore O’Neill
Other companies: Editas Medicine, Inc. (President and Chief Executive Officer · Since at least Jun 1, 2022); Unity Biotechnology Inc (Director · Dec 10, 2020 – Jun 21, 2024 · Past); Sarepta Therapeutics, Inc. (EVP, R&D & CMO · Jun 7, 2018 – Mar 3, 2021 · Past)
Director · Oct 19, 2021 – May 26, 2022 · Past
Andrew KiddPRESIDENT AND CEO, Director · Jan 3, 2023 – Jan 3, 2023 · Past
Ashish KhannaCFO AND CBO · Jun 20, 2018 – Jan 3, 2023 · Past
Torsten M MadsenChief Medical Officer · Jun 20, 2018 – Jan 28, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about Aptinyx Inc.